📑Fornitura di vaccini vari.
Procurement process summary
This process is to purchase Fornitura di vaccini vari.
This contract was awarded by 🇮🇹 Azienda sanitaria locale della provincia di Milano 2 for an amount of EUR 3,209 to 1 supplier. It was published on 2011-10-18 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇮🇹 Azienda sanitaria locale della provincia di Milano 2 Buying unitnot reported Publication date2011-10-18 Contest statusnot reported DescriptionFornitura di vaccini vari. N. gara 3421021.Awards
This award was granted to GlaxoSmithKline by Azienda sanitaria locale della provincia di Milano 2 for an amount of EUR 3,209. The procurement process was conducted through open for the category of goods. This is award number 6.
This contract has multiple awards. This is award number 6. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇮🇹 GlaxoSmithKline | EUR 3,209 | 6 |
Market context and opportunities
The execution of this contract allows the entity Azienda sanitaria locale della provincia di Milano 2 to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberIT_ocds-70d2nz-5274766d-477d-411f-9061-fd2be8ea35c5-award-6Publication date2011-10-18Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
